The investment objective of HDFC Pharma and Healthcare Fund Regular Growth is to provide long-term capital appreciation by investing predominantly in equity and equity related securities of pharma and healthcare companies. there is no assurance that the investment objective of the scheme will be realized.. HDFC Pharma and Healthcare Fund Regular Growth is very high risk. The new fund offer (NFO) period for HDFC Pharma and Healthcare Fund Regular Growth is 2023-09-14 to 2023-09-28 with minimum investment amount of ₹ 5,000
HDFC Pharma and Healthcare Fund Regular Growth NFO Details
HDFC Asset Management Co Ltd manages assets worth 564,815 crores and was set up on 3 July 2000. It's current offering of mutual fund schemes includes 38 equity,121 debt and 23 hybrid funds.
